File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Tripotassium dicitrato-bismuthate tablets v liquid in the treatment of duodenal ulcers

TitleTripotassium dicitrato-bismuthate tablets v liquid in the treatment of duodenal ulcers
Authors
Issue Date1985
Citation
New Zealand Medical Journal, 1985, v. 98 n. 775, p. 191-192 How to Cite?
AbstractThirty-five patients with duodenal ulcers were treated with tripotassium dicitrato-bismuthate (TDB) in a double-blind, double-dummy endoscopically controlled trial. Healing rates were comparable in patients treated with either tablet or liquid, 74% and 72% at four weeks and 89% in both groups at eight weeks. It is concluded that the tablet formulation of TDB is as effective as the liquid in the treatment of acute duodenal ulceration.
Persistent Identifierhttp://hdl.handle.net/10722/175636
ISSN
2005 Impact Factor: 0.45
2015 SCImago Journal Rankings: 0.269
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorLane, Men_US
dc.contributor.authorLee, Sen_US
dc.contributor.authorTasmanJones, Cen_US
dc.contributor.authorNicholson, Gen_US
dc.date.accessioned2012-11-26T09:00:13Z-
dc.date.available2012-11-26T09:00:13Z-
dc.date.issued1985en_US
dc.identifier.citationNew Zealand Medical Journal, 1985, v. 98 n. 775, p. 191-192en_US
dc.identifier.issn0028-8446en_US
dc.identifier.urihttp://hdl.handle.net/10722/175636-
dc.description.abstractThirty-five patients with duodenal ulcers were treated with tripotassium dicitrato-bismuthate (TDB) in a double-blind, double-dummy endoscopically controlled trial. Healing rates were comparable in patients treated with either tablet or liquid, 74% and 72% at four weeks and 89% in both groups at eight weeks. It is concluded that the tablet formulation of TDB is as effective as the liquid in the treatment of acute duodenal ulceration.en_US
dc.languageengen_US
dc.relation.ispartofNew Zealand Medical Journalen_US
dc.subject.meshAdulten_US
dc.subject.meshAgeden_US
dc.subject.meshAnti-Ulcer Agents - Administration & Dosageen_US
dc.subject.meshBismuth - Administration & Dosageen_US
dc.subject.meshClinical Trials As Topicen_US
dc.subject.meshDouble-Blind Methoden_US
dc.subject.meshDuodenal Ulcer - Drug Therapyen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshOrganometallic Compoundsen_US
dc.subject.meshSolutionsen_US
dc.subject.meshTabletsen_US
dc.titleTripotassium dicitrato-bismuthate tablets v liquid in the treatment of duodenal ulcersen_US
dc.typeArticleen_US
dc.identifier.emailLee, S: sumlee@hku.hken_US
dc.identifier.authorityLee, S=rp01351en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.pmid3885084-
dc.identifier.scopuseid_2-s2.0-0021950334en_US
dc.identifier.volume98en_US
dc.identifier.issue775en_US
dc.identifier.spage191en_US
dc.identifier.epage192en_US
dc.identifier.isiWOS:A1985AEP1000006-
dc.identifier.scopusauthoridLane, M=7401977312en_US
dc.identifier.scopusauthoridLee, S=7601417497en_US
dc.identifier.scopusauthoridTasmanJones, C=7003303326en_US
dc.identifier.scopusauthoridNicholson, G=7202313029en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats